Skip to content

Dr. Gyselynck

Active
Private limited companyfounded 2024active for 2 yearsDeltastraat 19A, 1190 Vorst, BelgiumKBO/BCE: BE 1009.886.596
Summary

Dr. Gyselynck has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €37,472 and a net result of €16,418. The computed 12-month bankruptcy probability is 1.3% (low).

Overview

Official details

Source: KBO
Status
Active since 30-05-2024 Normal situation
Activity
“La société a pour objet I'exercice en son nom et pour son compte de…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO yet
Establishment unit
2.360.187.073 1070 Anderlecht, since 30-05-2024
Financial year end
31 December
Peppol
Reachable since 26-12-2025

Board and ownership

Board

Financial position

67 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.3%
Annual accounts 2025
Gross margin
€61,610
▲ 149%
Turnover
≈ €190,000
estimated
Profit
€16,418
▼ 13.8%
Equity
€37,472
▲ 78.0%
Total assets
€89,297
▲ 156%
Score breakdownraises risk1 change of registered office in 24 monthsFounded in 2024No main activity registeredlowers riskLiquidity: current ratio 4.48, cash €82,606Show the evidence

Checked score

Score 2025
67 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 72% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 67-18
equity 42.0% of total assets
Liquidity 93+12
short-term debt 21.8% · cash 92.5%
Profitability 92-8
return on assets 18.4%
Bankruptcy probability within 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 06-2025: 7.3% 07-2025: 7.3%● unchanged vs 06-2025 08-2025: 7.4%▲ +0.1 percentage points vs 07-2025highest value 09-2025: 2.2%▼ -5.2 percentage points vs 08-2025 10-2025: 2.2%● unchanged vs 09-2025 11-2025: 2.2%● unchanged vs 10-2025 12-2025: 2.2%● unchanged vs 11-2025 01-2026: 2.2%● unchanged vs 12-2025 02-2026: 2.2%● unchanged vs 01-2026 03-2026: 2.3%▲ +0.1 percentage points vs 02-2026 04-2026: 2.8%▲ +0.5 percentage points vs 03-2026 05-2026: 3.3%▲ +0.5 percentage points vs 04-2026 06-2026: 3.6%▲ +0.3 percentage points vs 05-2026 07-2026: 3.8%▲ +0.2 percentage points vs 06-2026 08-2026: 1.3%▼ -2.5 percentage points vs 07-2026lowest value 09-2026: 1.3%● unchanged vs 08-2026lowest value 10-2026: 1.3%● unchanged vs 09-2026lowest value 11-2026: 1.3%● unchanged vs 10-2026lowest value
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.48 (2.43 in 2024), above the usual 1.5. Short-term debt is 21.8% and cash 92.5% of total assets. However, 58% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 40% of them on solvency, 84% on liquidity, 74% on profitability and 90% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 4.48, cash €82,606
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · No main activity registered
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
1 day early
2024
25 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 2 accounts on average 12 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Recent changes

  1. · Gazette deed Registered office moved from Etterbeek to ForestNew seat: Rue du Delta 19A, app 308 boite 26 - 1190 Forest · Previous seat: Avenue Jules Malou 61 - 1040 Etterbeek
  2. · Gazette deed IncorporationStarting capital €2,000 · Appointment: GYSELYNCK Mathilde Marie (director)
All 4 events

Key facts about Dr. Gyselynck

What is the company number of Dr. Gyselynck?
The company number of Dr. Gyselynck is 1009.886.596. The VAT number is the same number with BE in front: BE 1009.886.596.
Where is Dr. Gyselynck based?
The registered office is at Deltastraat 19A, 1190 Vorst.Company details
What is the legal form of Dr. Gyselynck?
The legal form of Dr. Gyselynck is Private limited company (BV).
When was Dr. Gyselynck founded?
Dr. Gyselynck was founded on 30-05-2024.
Is Dr. Gyselynck still active?
Yes, Dr. Gyselynck is an active enterprise in the KBO register.
What is the turnover of Dr. Gyselynck?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €61,610 and 2,666 comparable companies of the same size. It probably lies between €120,000 and €320,000. It is a rough estimate.Financials
Is Dr. Gyselynck profitable?
In financial year 2025, Dr. Gyselynck made a profit of €16,418.
Where can I find the annual accounts of Dr. Gyselynck?
Dr. Gyselynck filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Gyselynck due?
Dr. Gyselynck must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.